Five lifespan treatments in mice all raised one molecule: ergothioneine

2 months ago

Five completely different treatments that extend lifespan in mice. This study found they all raised the same molecule. It is called ergothioneine, and right now it is sold to people as the longevity vitamin. So is it the reason those treatments work? This preprint takes the first careful look.

Ask

Ask about this presentation

Answers are generated from this presentation.

Chapters

  1. 0:00Five lifespan treatments in mice all raised one molecule: ergothioneine
  2. 0:19Every treatment raised it in blood and brain.
  3. 0:35A midlife chemistry snapshot, not a survival study.
  4. 0:58The chemistry alone flags a treated mouse. In all seven tissues.
  5. 1:19The shared signature is bigger than one molecule.
  6. 1:43A shared marker, not yet a proven cause.
  7. 2:12A real fingerprint in mice. Not a longevity pill.
Show transcript

Five lifespan treatments in mice all raised one molecule: ergothioneine

That molecule is ergothioneine, sold right now as "the longevity vitamin."
bioRxiv preprint metabolomics + machine learning male UM-HET3 mice ~10–15 per group
So is it the reason those treatments work? This preprint takes the first careful look.
Badenoch et al. · bioRxiv 2026 · DOI 10.64898/2026.06.24.734388

Five completely different treatments that extend lifespan in mice. This study found they all raised the same molecule. It is called ergothioneine, and right now it is sold to people as the longevity vitamin. So is it the reason those treatments work? This preprint takes the first careful look.

Every treatment raised it in blood and brain.

Blood
(plasma)
Brain
Muscle
Rapamycin
↑
↑
↑
Acarbose
↑
↑
↑
17α-estradiol
↑
↑
✕
Canagliflozin
↑
↑
↑
Caloric restriction
↑
↑
↑
raised in
5 / 5
5 / 5
4 / 5
Pooled: significant Pool treated mice against controls and the rise holds in blood, brain, and muscle · two-tailed t-test, p<0.05
House rebuild of Fig 6 · direction + significance, no fold-change printed · 17α-estradiol the muscle exception · Badenoch et al., bioRxiv 2026 (CC BY 4.0)

In these male mice, all five treatments raised ergothioneine in the blood and in the brain. Four of the five raised it in muscle too. Only 17-alpha-estradiol did not. Pool the treated mice against controls, and the rise is significant in blood, brain, and muscle alike.

A midlife chemistry snapshot, not a survival study.

From 4 months of age, each male mouse got one of five treatments, then seven tissues were sampled at midlife.
Rapamycin
14.7 ppm
NIA ITP lifespan extender
Acarbose
1000 ppm
NIA ITP lifespan extender
17α-estradiol
14 ppm
NIA ITP lifespan extender
Canagliflozin
180 ppm
NIA ITP lifespan extender
Caloric restriction
60% intake
simply eating less
male UM-HET3 mice · ~10–15/group treated from 4 months 7 tissues sampled at 11–12 months untargeted metabolomics → XGBoost
No survival here This study measured no survival of its own. The four drugs' lifespan extension comes from prior NIA survival studies.
Doses + ages from Methods/Results · ITP provenance from Intro · research.md rows 10–13

From four months of age, each mouse got one of five treatments. Four are drugs the National Institute on Aging has already shown extend lifespan in these mice. The fifth is simply eating less. At eleven to twelve months, still midlife, they measured the chemistry of seven tissues. This study measured no survival of its own. It is a chemistry snapshot, not a lifespan experiment.

The chemistry alone flags a treated mouse. In all seven tissues.

Train on any 4
a model learns the chemistry of control mice and four of the treatments
→
Test the unseen 5th
show it mice from the fifth treatment it never trained on
→
Treated mice stand out
from the chemistry alone, treated mice score apart from controls
✓ plasma ✓ brain ✓ perigonadal fat ✓ inguinal fat ✓ liver ✓ muscle ✓ kidney
all 7 tissues treated separated from control in every tissue · p<0.05 to p<0.001
Measured at midlife, 11–12 months, before the survival curves would ever diverge.
House rebuild · leave-one-intervention-out XGBoost regression (Figs 1–4, Panel A) · research.md rows 6–8

Now the strongest result. They trained a machine-learning model on any four of the treatments, then showed it mice from a fifth it had never seen. From the chemistry alone, it could separate treated mice from untreated ones, in all seven tissues, every one significant. And this is still midlife. The treated state is readable in the chemistry months before the survival curves would ever diverge.

The shared signature is bigger than one molecule.

↑ Long-chain polyunsaturated triglycerides rose plasma
↓ Short-chain saturated triglycerides fell plasma
↓ Diacylglycerols fell plasma
↑ Fatty acids rose perigonadal fat
↑ Phosphatidylcholines rose kidney
The catch Mammals cannot make ergothioneine. It comes entirely from the diet, taken up by the transporter SLC22A4 (OCTN1).
So more of it in a tissue can mean the mouse absorbed more, not that it was protected more.
House rebuild of Fig 5 lipid-class directions · diet-derived framing verbatim (quotes.md) · research.md rows 9, 16

This signature is broader than one molecule. Across tissues, the same treatments reshaped the animals' fats. In the blood, long-chain polyunsaturated fats rose while short, saturated ones fell. And here is the catch. Mammals cannot make ergothioneine. It comes entirely from the diet, taken up by a dedicated transporter. So more of it in a tissue can simply mean the mouse absorbed more, not that it was protected more.

A shared marker, not yet a proven cause.

"It is not yet clear if increased tissue levels of ergothioneine convey health benefits, or if elevated tissue ergothioneine is a surrogate marker for increased absorption of other materials that are important to health maintenance."
— the authors, Badenoch et al., bioRxiv 2026
In plain terms, no one in this study fed ergothioneine to a mouse. The authors say that is the experiment still to be done.
preprint · not yet peer-reviewed male mice only no survival endpoint here no one fed ergothioneine to test it
Verbatim author hedge + the "administer ergothioneine to mice" call (quotes.md) · research.md rows 14–15

The authors are careful here, so let me quote them. It is not yet clear, they write, whether higher tissue ergothioneine conveys health benefits, or whether it is just a marker for absorbing other things that matter. In plain terms, no one in this study fed ergothioneine to a mouse. The authors say that is the experiment still to be done. And this is a preprint, not yet peer-reviewed. Male mice only. No survival measured. Ergothioneine is a shared fingerprint of the treated state, not a proven cause.

A real fingerprint in mice. Not a longevity pill.

Five very different lifespan-extending treatments converge on one diet-derived molecule, ergothioneine, in male mice.
In this preprint it marks the treated state. It has not been shown to cause it, and nothing here is a reason to buy the supplement.
DOI 10.64898/2026.06.24.734388 · Badenoch et al., bioRxiv 2026

So the takeaway. Five very different treatments that extend lifespan in mice really do converge on one diet-derived molecule. But in this preprint, ergothioneine marks the treated state. It has not been shown to cause it. And nothing here is a reason to go and buy the supplement.